TEVA-TRAZODONE 100 MG — DIN 02144271
TRAZODONE HYDROCHLORIDE : 100 MG · TEVA CANADA LIMITED · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is TEVA-TRAZODONE?
TEVA-TRAZODONE 100 MG contains TRAZODONE HYDROCHLORIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02144271, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 15-Jun-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-TRAZODONE used for?
Symptomatic relief of depressive illness.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Trazodone cost around the world?
Trazodone is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Greece publishes a producer price (ex-factory); Hungary publishes a producer price (ex-factory); Iceland publishes a max wholesale. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 4 | 81 | USD███.██ |
| Italy | prezzo al pubblico (classe A) | 8 | 8 | EUR███.██ |
| United Kingdom | hospital | 4 | 4 | GBP███.██ |
| Greece | producer price (ex-factory) | 3 | 3 | EUR███.██ |
| Hungary | producer price (ex-factory) | 2 | 3 | HUF███.██ |
| Saudi Arabia | public | 2 | 2 | SAR███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
104 pack listings across 26 brand entries and 7 price bases, refreshed 03 Sep 2026. Ranges span every Trazodone pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Trazodone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
20 holders have a Canadian DIN containing Trazodone, across 57 DINs, of which 21 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 9 | 3 | NTP-TRAZODONE, RATIO-TRAZODONE, TEVA-TRAZODONE | Sourceable in Canada |
| ANGITA PHARMA INC. | 3 | 3 | AG-TRAZODONE | Sourceable in Canada |
| APOTEX INC | 3 | 3 | APO-TRAZODONE D TABLETS 150MG, APO-TRAZODONE TABLETS 100MG, APO-TRAZODONE TABLETS 50MG | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 3 | 3 | JAMP TRAZODONE | Sourceable in Canada |
| PRO DOC LIMITEE | 3 | 3 | TRAZODONE-100, TRAZODONE-150 D, TRAZODONE-50 | Sourceable in Canada |
| SANIS HEALTH INC | 3 | 3 | TRAZODONE | Sourceable in Canada |
| PHARMASCIENCE INC | 2 | 2 | PMS TRAZODONE HCL TAB 100MG, PMS-TRAZODONE | Sourceable in Canada |
| PHARMASCIENCE INC 100 6111 Royalmount Ave Montreal Quebec Canada H4P 2T4 | 1 | 1 | PMS TRAZODONE HCL TAB 50MG | Sourceable in Canada |
| BRISTOL-MYERS SQUIBB CANADA | 3 | 0 | DESYREL DIVIDOSE TABLET 150 MG, DESYREL TAB 100MG, DESYREL TAB 50MG | No marketed DIN |
| MYLAN PHARMACEUTICALS ULC | 3 | 0 | MYLAN-TRAZODONE | No marketed DIN |
| NU-PHARM INC | 3 | 0 | NU-TRAZODONE - TAB 100MG, NU-TRAZODONE - TAB 50MG, NU-TRAZODONE-D - TAB 150MG | No marketed DIN |
| ZYMCAN PHARMACEUTICALS INC | 3 | 0 | ZYM-TRAZODONE | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | Bottles of 100, 500, and 1000 tablets; unit dose strips of 100. |
| Storage | Store between 15-30°C and protect from light. Unit dose strips: 15-25°C, protect from light and high humidity. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Trazodone |
|---|---|
| ATC code | N06AX05 |
| AHFS class | 28:16.04.24 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02144271 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2144271 |
| Brand name | TEVA-TRAZODONE |
| Generic / active ingredient | TRAZODONE HYDROCHLORIDE : 100 MG |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | N06AX05 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N06AX |
| Current status | MARKETED |
| Status date | 15-Jun-2011 |
| Original market date | 1995-01-18 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Initial: 150-200 mg/day in divided doses after meals. Increase by 50 mg increments up to 300 mg/day. Max 400-600 mg/day in hospitalized patients. Elderly: use half adult dose.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Known hypersensitivity to trazodone.
Warnings and precautions
Risk of priapism (may require surgery); arrhythmogenic potential (monitor cardiac patients); angle-closure glaucoma; potential for suicide ideation; may impair ability to drive/operate machinery.
Is Trazodone in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANIS HEALTH INC (Tier 3 Drug Shortages About & Resources), last seen 19 Aug 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
21 of 57 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-TRAZODONE | 150 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02537923 |
| AG-TRAZODONE | 50 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02537907 |
| AG-TRAZODONE | 100 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02537915 |
| APO-TRAZODONE D TABLETS 150MG | 150 MG | TABLET | APOTEX INC | MARKETED | 02147653 |
| APO-TRAZODONE TABLETS 100MG | 100 MG | TABLET | APOTEX INC | MARKETED | 02147645 |
| APO-TRAZODONE TABLETS 50MG | 50 MG | TABLET | APOTEX INC | MARKETED | 02147637 |
| JAMP TRAZODONE | 150 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02442825 |
| JAMP TRAZODONE | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02442809 |
| JAMP TRAZODONE | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02442817 |
| PMS TRAZODONE HCL TAB 100MG | 100 MG | TABLET | PHARMASCIENCE INC | MARKETED | 01937235 |
2 · Same class — other molecules in ATC N06AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Venlafaxine | ACT VENLAFAXINE XR · APO-VENLAFAXINE XR · AURO-VENLAFAXINE XR · DOM-VENLAFAXINE XR · +19 more | 90 | 36 | Yes |
| Duloxetine | ACCEL-DULOXETINE · AG-DULOXETINE · APO-DULOXETINE · AURO-DULOXETINE · +24 more | 66 | 36 | Yes |
| Mirtazapine | APO-MIRTAZAPINE · AURO-MIRTAZAPINE · AURO-MIRTAZAPINE OD · AVA-MIRTAZAPINE · +24 more | 64 | 31 | Yes |
| Trazodone | AG-TRAZODONE · APO-TRAZODONE D TABLETS 150MG · APO-TRAZODONE TABLETS 100MG · APO-TRAZODONE TABLETS 50MG · +30 more | 57 | 21 | Yes |
| Desvenlafaxine | AG-DESVENLAFAXINE · APO-DESVENLAFAXINE · APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS · DESVENLAFAXINE · +8 more | 28 | 20 | Yes |
| Tryptophan | APO-TRYPTOPHAN · DOM-TRYPTOPHAN · PHL-TRYPTOPHAN · PMS-TRYPTOPHAN · +2 more | 20 | 11 | Yes |
| Bupropion | AVA-BUPROPION SR · BUPROPION HCL SR · BUPROPION HCL XL · BUPROPION SR · +13 more | 32 | 9 | Yes |
| Vortioxetine | APO-VORTIOXETINE · TRINTELLIX | 8 | 6 | Yes |
| Vilazodone | APO-VILAZODONE · VIIBRYD | 8 | 6 | Yes |
| Levomilnacipran | FETZIMA | 4 | 4 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N06AB | Citalopram · Escitalopram · Fluoxetine · Fluvoxamine · Paroxetine · +1 more | 589 | 248 |
| N06AA | Amitriptyline · Amoxapine · Clomipramine · Desipramine · Doxepin · +5 more | 325 | 62 |
| N06AG | Moclobemide | 21 | 4 |
| N06AF | Tranylcypromine | 2 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TEVA-TRAZODONE called?
The same molecule, Trazodone, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Desyrel | Latin | Saudi Arabia |
| Trazodone | Latin | Iceland |
| Trazodone QO | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.